Frulac 20 Tablet
by Orion Pharma Ltd.
৳9.00
GENERAL Pharmaceuticals Ltd.
Furosemide + Spironolactone
Lacitone is indicated for -
Spironolactone (potassium-sparing diuretic) and furosemide (loop diuretic) have different but complementary mechanisms and sites of action. Therefore, when they are administered together, they will produce an additional or synergistic diuretic. The furosemide component inhibits the Na+/K+/2Cl cotransporter in the Henlesheng ring and blocks the reabsorption of sodium, potassium, and chloride ions; thereby increasing the amount of sodium and water excreted in the urine. This characteristically leads to potassium loss. The spironolactone component inhibits the reabsorption of potassium by sodium in the distal tubules by antagonizing the effect of aldosterone, thereby greatly increasing sodium excretion and reducing excessive potassium loss caused by furosemide.
1 to 4 tablets daily, (20 to 80 mg of Furosemide and 50 to 200 mg of Spironolactone) according to patient's response.
Drug interaction may occur with the following drugs: ACE inhibitors, potassium salts, Cardiac glycosides, Corticosteroids, NSAIDs.
Lacitone is contraindicated in patient with hyperkalemia, hyponatremia, acute renal insufficiency and hypersensitivity to Furosemide or to Spironolactone or to any ingredient containing this product.
Fatigue, nausea, malaise, gastric upset, headache, hypotension, skin rash.
Lacitone should be used with caution during pregnancy and only if expected benefit to mother is greater than the possible risk to the fetus. Furosemide passes into breast milk. It's not recommended while breast feeding.
Electrolyte imbalance should be monitored. Special precaution should be taken in patients of diabetes, prostatic hypertrophy, hypotension, hypovolemia.
Potassium-sparing diuretics, Potassium-sparing diuretics & Aldosterone antagonists
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
General Pharmaceuticals Ltd.
by Drug International Limited
৳7.00